,AID,AID Version,AID Revision,Panel Member ID,SID,CID,Bioactivity Outcome,Target GI,Target GeneID,Activity Value [uM],Activity Name,Assay Name,Bioassay Type,PubMed ID,RNAi
0,248,1,1,,422198,176,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
1,248,1,1,,476220,176,Inactive,,,,,NCI In Vivo Anticancer Drug Screen. Data for tumor model  L1210 Leukemia (intraperitoneal) in B6D2F1 (BDF1) mice,Other,,
2,17814,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice blood after 120 hr,Other,10425108.0,
3,17815,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice blood after 24 hr,Other,10425108.0,
4,17816,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice blood after 4 hr,Other,10425108.0,
5,17817,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice bone after 120 hr,Other,10425108.0,
6,17818,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice bone after 24 hr,Other,10425108.0,
7,17819,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice bone after 4 hr,Other,10425108.0,
8,17820,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice heart after 120 hr,Other,10425108.0,
9,17821,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice heart after 24 hr,Other,10425108.0,
10,17822,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice heart after 4 hr,Other,10425108.0,
11,17823,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice kidney after 120 hr,Other,10425108.0,
12,17824,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice kidney after 24 hr,Other,10425108.0,
13,17825,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice kidney after 4 hr,Other,10425108.0,
14,17826,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice liver after 120 hr,Other,10425108.0,
15,17827,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice liver after 24 hr,Other,10425108.0,
16,17828,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice liver after 4 hr,Other,10425108.0,
17,17829,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice spleen after 120 hr,Other,10425108.0,
18,17830,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice spleen after 24 hr,Other,10425108.0,
19,17831,6,1,,103176092,176,Unspecified,,,,,Biodistribution in normal mice spleen after 4 hr,Other,10425108.0,
20,23251,3,3,,103176092,176,Unspecified,,,,,Partition coefficient (logP),Other,3599019.0,
21,23252,3,3,,103176092,176,Unspecified,,,,,Partition coefficient (logP) (benzene),Other,3599019.0,
22,23253,3,3,,103176092,176,Unspecified,,,,,Partition coefficient (logP) (carbon tetrachloride),Other,3599019.0,
23,23254,3,3,,103176092,176,Unspecified,,,,,Partition coefficient (logP) (chloroform),Other,3599019.0,
24,23255,3,3,,103176092,176,Unspecified,,,,,Partition coefficient (logP) (ether),Other,3599019.0,
25,23256,3,3,,103176092,176,Unspecified,,,,,Partition coefficient (logP) (hexane),Other,3599019.0,
26,23443,3,3,,103176092,176,Unspecified,,,,,Partition coefficient (logP),Other,3882967.0,
27,72281,7,2,,103176092,176,Active,,,0.9,Kd,Dissociation constant for binding to SH2 domain of Fyn protein kinase,Confirmatory,10072676.0,
28,224294,7,2,,103176092,176,Active,,,0.64,Kd,Dissociation constant for binding to SH2 domain of p56 lck tyrosine kinase,Confirmatory,10072676.0,
29,227555,3,3,,103176092,176,Unspecified,,,,,Affinity for Vancomycin (Exp I),Other,10579833.0,
30,227556,3,3,,103176092,176,Unspecified,,,,,Affinity for Vancomycin (Exp II),Other,10579833.0,
31,227718,7,1,,103176092,176,Unspecified,,,,,Binding energy by using the equation deltaG obsd = -RT ln KD,Other,6094812.0,
32,237685,4,3,,103176092,176,Unspecified,,,,,Lipophilicity determined as logarithm of the partition coefficient in the alkane/water system,Other,15857133.0,
33,342464,3,3,,103176092,176,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,18570365.0,
34,448096,3,3,,103176092,176,Unspecified,,,,,"Dissociation constant, pKa of the compound",Other,19646864.0,
35,452626,3,3,,103176092,176,Active,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by microscopic analysis,Other,19837596.0,
36,452627,3,3,,103176092,176,Active,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in DAF16 transcription factor mRNA expression at 50 ppm after 2 days by quantitative RT-PCR analysis,Other,19837596.0,
37,452628,3,3,,103176092,176,Active,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as decrease in DAF2 receptor mRNA expression at 50 ppm after 2 days by quantitative RT-PCR analysis,Other,19837596.0,
38,452629,3,4,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by microscopic analysis relative to control,Other,19837596.0,
39,452630,3,4,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm after 2 weeks by microscopic analysis relative to control,Other,19837596.0,
40,452631,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of vit6 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
41,452632,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of probable voltage-dependent anion-selective channel protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
42,452633,3,3,,103176092,176,Unspecified,,,,,"Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of ATPA synthase subunit alpha, mitochondrial precursor protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis",Other,19837596.0,
43,452634,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of aspartate aminotransferase protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
44,452635,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of nucleoside diphosphate kinase protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
45,452636,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of mlc3 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
46,452637,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of mlc1 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
47,452638,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of tropomyosin isoform A protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
48,452639,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of tropomyosin isoform B protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
49,452640,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of tropomyosin isoform D protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
50,452641,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of tropomyosin isoform F protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
51,452642,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of HSP12.2 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
52,452643,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of rack1 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
53,452644,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of rpl5 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
54,452645,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of mdh1 protein expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
55,452646,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as ratio of major sperm protein-3 expression in stress to normal condition at 50 ppm after 3 days by second-dimensional electrophoresis/image analysis coupled with LC-MS/MS analysis,Other,19837596.0,
56,452647,3,3,,103176092,176,Active,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in GFP-fused DAF16 transcription factor mRNA expression at 50 ppm by quantitative RT-PCR analysis,Other,19837596.0,
57,452648,6,1,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as survival time at 50 ppm by fluorescent microscopy,Other,19837596.0,
58,452649,3,3,,103176092,176,Unspecified,,,,,Longevity-promoting activity in wild type Caenorhabditis elegans N2 assessed as increase in lifespan at 50 ppm by fluorescent microscopy relative to control,Other,19837596.0,
59,454554,6,6,,103176092,176,Unspecified,3122160.0,2867.0,120.0,IC50,Agonist activity at human FFA2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production,Confirmatory,20005104.0,
60,454564,3,10,,103176092,176,Unspecified,3122160.0,2867.0,,,Agonist activity at human FFA2 receptor expressed in CHO cells assessed as inhibition of forskolin-induced cAMP production relative to acetate,Other,20005104.0,
61,498773,2,4,,103176092,176,Unspecified,,,,,Toxicity in po dosed ICR mouse assessed as decreased in mobility after 3 hrs,Other,19465932.0,
62,498775,5,2,,103176092,176,Unspecified,,,,,Toxicity in po dosed mouse,Other,19465932.0,
63,588211,2,3,,103176092,176,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in humans",Other,20014752.0,
64,588212,2,3,,103176092,176,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in rodents",Other,20014752.0,
65,588213,2,3,,103176092,176,Unspecified,,,,,"Literature-mined compound from Fourches et al multi-species drug-induced liver injury (DILI) dataset, effect in non-rodents",Other,20014752.0,
66,625279,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for bilirubinemia,Other,22194678.0,
67,625280,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholecystitis,Other,22194678.0,
68,625281,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cholelithiasis,Other,22194678.0,
69,625282,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for cirrhosis,Other,22194678.0,
70,625283,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for elevated liver function tests,Other,22194678.0,
71,625284,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic failure,Other,22194678.0,
72,625285,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatic necrosis,Other,22194678.0,
73,625286,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatitis,Other,22194678.0,
74,625287,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for hepatomegaly,Other,22194678.0,
75,625288,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for jaundice,Other,22194678.0,
76,625289,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver disease,Other,22194678.0,
77,625290,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver fatty,Other,22194678.0,
78,625291,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) score for liver function tests abnormal,Other,22194678.0,
79,625292,1,3,,103176092,176,Unspecified,,,,,Drug Induced Liver Injury Prediction System (DILIps) training set; hepatic side effect (HepSE) combined score,Other,22194678.0,
80,627874,1,4,,103176092,176,Inactive,,,,,Inhibition of calf DNA polymerase alpha using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
81,627875,1,4,,103176092,176,Inactive,,,,,Inhibition of histidine-tagged human DNA polymerase gamma using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
82,627876,1,9,,103176092,176,Inactive,59798438.0,51426.0,,,Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
83,627877,1,4,,103176092,176,Inactive,,,,,Inhibition of calf DNA polymerase alpha using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
84,627878,1,4,,103176092,176,Inactive,,,,,Inhibition of histidine-tagged human DNA polymerase gamma using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
85,627879,1,9,,103176092,176,Inactive,59798438.0,51426.0,,,Inhibition of C-terminal His6-tagged human DNA polymerase kappa (amino acids 1 to 560) using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
86,627880,1,9,,103176092,176,Inactive,17367126.0,27343.0,,,Inhibition of recombinant His-tagged human DNA polymerase lambda using bovine deoxyribonuclease 1-treated DNA and dNTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
87,627976,2,1,,103176092,176,Inactive,,,,LD50,Cytotoxicity against human HCT116 cells by WST-1 assay,Confirmatory,21903399.0,
88,627979,1,4,,103176092,176,Inactive,,,,,Antiinflammatory activity in mouse RAW264.7 cells assessed as inhibition of LPS-induced TNFalpha secretion at 5 uM treated 30 mins before LPS challenge measured after 24 hrs by ELISA,Other,21903399.0,
89,627980,1,4,,103176092,176,Unspecified,,,,,Cytotoxicity against mouse RAW264.7 cells at 5 uM,Other,21903399.0,
90,627981,2,1,,103176092,176,Unspecified,,,10.0,LD50,Cytotoxicity against mouse RAW264.7 cells,Confirmatory,21903399.0,
91,627982,1,4,,103176092,176,Inactive,,,,,Antiinflammatory activity in mouse assessed as inhibition of TPA-induced mouse ear edema at 500 ug/ear administered 30 mins before TPA challenge measured after 7 hrs relative to untreated control,Other,21903399.0,
92,628060,1,9,,103176092,176,Inactive,17367126.0,27343.0,,,Inhibition of recombinant His-tagged human DNA polymerase lambda using poly(dA)/oligo(dT)18 (A/T = 2/1) and dTTP as the DNA template-primer and nucleotide substrate at 10 uM after 60 mins,Other,21903399.0,
93,651631,4,1,,144211770,176,Inactive,269849759.0,7157.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway,Confirmatory,,
94,651632,4,1,,144211770,176,Inactive,296439460.0,79915.0,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5,Confirmatory,,
95,651633,4,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the p53 signaling pathway - cell viability,Confirmatory,,
96,651634,4,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5 - cell viability,Confirmatory,,
97,679427,1,8,,103176092,176,Unspecified,313104012.0,11309.0,,,TP_TRANSPORTER: uptake (pH 7.4) of Acetic acid at a concentration of 4.94 u M in OATP-B-expressing HEK293 cells,Other,14610227.0,
98,679436,1,8,,103176092,176,Unspecified,313104012.0,11309.0,,,TP_TRANSPORTER: uptake (pH 5.0) of Acetic acid at a concentration of 4.94 u M in OATP-B-expressing HEK293 cells,Other,14610227.0,
99,679446,1,8,,103176092,176,Unspecified,313104012.0,11309.0,,,"TP_TRANSPORTER: inhibition of E1S uptake (E1S: 0.00476 uM, acetic acid: 10000 uM) in OATP-B-expressing HEK293 cells",Other,12724351.0,
100,679837,1,7,,103176092,176,Unspecified,1709076.0,25027.0,,,TP_TRANSPORTER: uptake of Acetic Acid at a concentration of 6uM in MCT1-expressing MDA-MB231 cells,Other,10579682.0,
101,720516,2,1,,144211770,176,Inactive,296439460.0,79915.0,,ATAD5 Potency (uM),qHTS assay for small molecules that induce genotoxicity in human embryonic kidney cells expressing luciferase-tagged ATAD5: Summary,Summary,,
102,720552,2,1,,144211770,176,Inactive,269849759.0,7157.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the p53 signaling pathway: Summary,Summary,,
103,720634,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential - cell viability,Confirmatory,,
104,720635,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule disruptors of the mitochondrial membrane potential,Confirmatory,,
105,720637,2,1,,144211770,176,Inactive,,,,Ratio Potency (uM),qHTS assay for small molecule disruptors of the mitochondrial membrane potential: Summary,Summary,,
106,720674,2,2,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cells,Confirmatory,,
107,720675,2,2,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cells,Confirmatory,,
108,720678,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cells,Confirmatory,,
109,720679,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cells,Confirmatory,,
110,720680,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cells,Confirmatory,,
111,720681,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HEK293 cell free culture,Confirmatory,,
112,720682,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HEK293 cell free culture,Confirmatory,,
113,720683,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HEK293 cell free culture,Confirmatory,,
114,720684,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 590 nm (red) in HepG2 cell free culture,Confirmatory,,
115,720685,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cell free culture,Confirmatory,,
116,720686,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 535 nm (green) in HepG2 cell free culture,Confirmatory,,
117,720687,2,2,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to test for compound auto fluorescence at 460 nm (blue) in HepG2 cells,Confirmatory,,
118,720691,4,1,,144211770,176,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
119,720692,3,1,,144211770,176,Inactive,311348376.0,2908.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway,Confirmatory,,
120,720693,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway - cell viability counter screen,Confirmatory,,
121,720719,2,1,,144211770,176,Inactive,311348376.0,2908.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
122,720725,2,1,,144211770,176,Inactive,311348376.0,2908.0,,,qHTS assay to identify small molecule antagonists of the glucocorticoid receptor (GR) signaling pathway: Summary,Summary,,
123,743012,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - wild type cell line,Confirmatory,,
124,743014,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rev3 mutant cell line,Confirmatory,,
125,743015,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for identifying genotoxic compounds that show differential cytotoxicity against isogenic chicken DT40 cell lines with known DNA damage response pathways - Rad54/Ku70 mutant cell line,Confirmatory,,
126,743033,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway - cell viability counter screen,Confirmatory,,
127,743035,2,1,,144211770,176,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
128,743036,2,1,,144211770,176,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway,Confirmatory,,
129,743040,3,1,,144211770,176,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
130,743041,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line - cell viability counter screen,Confirmatory,,
131,743042,3,1,,144211770,176,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen  receptor (AR) signaling pathway using the MDA cell line,Confirmatory,,
132,743053,2,1,,144211770,176,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
133,743054,2,1,,144211770,176,Inactive,124375976.0,367.0,,AR Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line: Summary,Summary,,
134,743063,2,1,,144211770,176,Inactive,124375976.0,367.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway: Summary,Summary,,
135,743064,3,1,,144211770,176,Inconclusive,,,3.8571,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway - cell viability counter screen,Confirmatory,,
136,743065,3,1,,144211770,176,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
137,743066,3,1,,144211770,176,Inactive,399498506.0,24831.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid receptor (TR) signaling pathway,Confirmatory,,
138,743067,2,1,,144211770,176,Inactive,399498506.0,24831.0,,TR Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid receptor (TR) signaling pathway: Summary,Summary,,
139,743069,2,1,,144211770,176,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
140,743074,2,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway - cell viability counter screen,Confirmatory,,
141,743075,2,1,,144211770,176,Inactive,348019627.0,2099.0,0.0195,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway,Confirmatory,,
142,743077,2,1,,144211770,176,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
143,743078,2,1,,144211770,176,Inactive,348019627.0,2099.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway: Summary,Summary,,
144,743079,3,1,,144211770,176,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
145,743080,3,1,,144211770,176,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line,Confirmatory,,
146,743081,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line - cell viability counter screen,Confirmatory,,
147,743083,3,1,,144211770,176,Inactive,119597822.0,1588.0,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors,Confirmatory,,
148,743084,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify aromatase inhibitors - cell viability counter screen,Confirmatory,,
149,743085,3,1,,144211770,176,Inactive,51095037.0,196.0,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway,Confirmatory,,
150,743086,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway - cell viability counter screen,Confirmatory,,
151,743091,2,1,,144211770,176,Inactive,348019627.0,2099.0,,ER Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line: Summary,Summary,,
152,743094,3,1,,144211770,176,Inactive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
153,743122,2,1,,144211770,176,Inactive,51095037.0,196.0,,AhR Potency (uM),qHTS assay to identify small molecule that activate the aryl hydrocarbon receptor (AhR) signaling pathway: Summary,Summary,,
154,743139,2,1,,144211770,176,Inactive,119597822.0,1588.0,,,qHTS assay to identify aromatase inhibitors: Summary,Summary,,
155,743140,2,1,,144211770,176,Inactive,216409692.0,5468.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
156,743191,3,1,,144211770,176,Inconclusive,216409692.0,5468.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway,Confirmatory,,
157,743194,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway - cell viability counter screen,Confirmatory,,
158,743199,2,1,,144211770,176,Inactive,216409692.0,5468.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor gamma (PPARg) signaling pathway: Summary,Summary,,
159,743202,4,1,,144211770,176,Inactive,20149576.0,4780.0,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway,Confirmatory,,
160,743203,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway - cell viability counter screen,Confirmatory,,
161,743209,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway - cell viability counter screen,Confirmatory,,
162,743210,4,1,,144211770,176,Inactive,4504517.0,3315.0,,Potency-Replicate_1,qHTS assay for small molecule activators of the heat shock response signaling pathway,Confirmatory,,
163,743211,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
164,743212,3,1,,144211770,176,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
165,743213,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway - cell viability counter screen,Confirmatory,,
166,743215,3,1,,144211770,176,Inactive,216409690.0,5467.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway,Confirmatory,,
167,743217,3,1,,144211770,176,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
168,743218,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
169,743219,3,1,,144211770,176,Inactive,20149576.0,4780.0,,Ratio Potency (uM),qHTS assay for small molecule agonists of the antioxidant response element (ARE) signaling pathway: Summary,Summary,,
170,743220,3,1,,144211770,176,Inactive,325495553.0,9971.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway,Confirmatory,,
171,743221,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway - cell viability counter screen,Confirmatory,,
172,743222,3,1,,144211770,176,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
173,743223,3,1,,144211770,176,Inactive,216409708.0,7421.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway,Confirmatory,,
174,743224,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
175,743225,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway - cell viability counter screen,Confirmatory,,
176,743226,2,1,,144211770,176,Inactive,216409690.0,5467.0,,,qHTS assay to identify small molecule antagonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
177,743227,2,1,,144211770,176,Inactive,216409690.0,5467.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the peroxisome proliferator-activated receptor delta (PPARd) signaling pathway: Summary,Summary,,
178,743228,3,1,,144211770,176,Inactive,4504517.0,3315.0,,Ratio Potency (uM),qHTS assay for small molecule activators of the heat shock response signaling pathway: Summary,Summary,,
179,743239,2,1,,144211770,176,Inactive,325495553.0,9971.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
180,743240,2,1,,144211770,176,Inactive,325495553.0,9971.0,,,qHTS assay to identify small molecule antagonists of the farnesoid-X-receptor (FXR) signaling pathway: Summary,Summary,,
181,743241,2,1,,144211770,176,Inactive,216409708.0,7421.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
182,743242,2,1,,144211770,176,Inactive,216409708.0,7421.0,,,qHTS assay to identify small molecule antagonists of the vitamin D receptor (VDR) signaling pathway: Summary,Summary,,
183,781325,1,2,,103176092,176,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Liao ref: J Chem Info Model 2009,Other,24249037.0,
184,781326,1,2,,103176092,176,Unspecified,,,,,pKa (acid-base dissociation constant) as determined by Avdeef ref: DOI: 10.1002/047145026X,Other,24249037.0,
185,1081607,1,1,,103176092,176,Active,,,,,"Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
186,1081608,1,1,,103176092,176,Active,,,,,"Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
187,1081609,1,1,,103176092,176,Active,,,,,"Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
188,1081610,1,1,,103176092,176,Active,,,,,"Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
189,1081611,1,1,,103176092,176,Active,,,,,"Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
190,1081612,1,1,,103176092,176,Active,,,,,"Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to 1,8-Cineole",Other,20715837.0,
191,1081616,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
192,1081617,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
193,1081618,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
194,1081622,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as seed germination at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
195,1081623,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as shoot length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
196,1081625,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as root length at 0.1 mol/l at 25 degC after 72 hr by laboratory-based agar medium bioassay relative to control,Other,20715837.0,
197,1081637,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress shoot growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
198,1081638,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress seed germination at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
199,1081639,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Lolium rigidum seeds assessed as concentration required to suppress root growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
200,1081640,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress seed germination at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
201,1081641,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress shoot growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
202,1081642,1,1,,103176092,176,Unspecified,,,,,Pre-emergence herbicidal activity against Raphanus sativus var.Long scarlet (radish) seeds assessed as concentration required to suppress root growth at 25 degC after 72 hr by laboratory-based agar medium bioassay,Other,20715837.0,
203,1081754,1,1,,103176092,176,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) assessed as paralysis measured after 1 day at 28 degC,Other,20925380.0,
204,1081755,1,1,,103176092,176,Unspecified,,,,,Nematicidal activity against Meloidogyne incognita J2 (root-knot nematode) assessed as paralysis measured after 1 hr at 28 degC,Other,20925380.0,
205,1083147,1,1,,103176092,176,Active,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of microscopic damages at 100 ug/mL measured 24 hr after immersion in compound test solutions,Other,23136941.0,
206,1083149,1,1,,103176092,176,Unspecified,,,,,Nematotoxic activity against freshly hatched Meloidogyne incognita J2 (root-knot nematode) isolated from tomato roots assessed as induction of nematode paralysis measured 24 hr after immersion in compound test solutions,Other,23136941.0,
207,1083150,1,1,,103176092,176,Unspecified,,,,,Nematotoxic activity against Meloidogyne incognita (root-knot nematode),Other,23136941.0,
208,1134605,2,1,,103176092,176,Unspecified,,,,,"Oil-water partition coefficient, log P of the compound",Other,894678.0,
209,1134606,2,1,,103176092,176,Unspecified,,,,,"Et2O-water partition coefficient, log P of the compound",Other,894678.0,
210,1159509,1,1,,144211770,176,Inactive,119626539.0,4790.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway,Confirmatory,,
211,1159515,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the NFkB signaling pathway - cell viability counter screen,Confirmatory,,
212,1159516,1,1,,144211770,176,Inactive,119611100.0,22926.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway,Confirmatory,,
213,1159517,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway - cell viability counter screen,Confirmatory,,
214,1159518,1,1,,144211770,176,Inactive,119626539.0,4790.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the NFkB signaling pathway: Summary,Summary,,
215,1159519,1,1,,144211770,176,Inactive,119611100.0,22926.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the endoplasmic reticulum stress response signaling pathway: Summary,Summary,,
216,1159520,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway - cell viability counter screen,Confirmatory,,
217,1159521,1,1,,144211770,176,Inactive,15928672.0,19885.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway,Confirmatory,,
218,1159523,1,1,,144211770,176,Inactive,15928672.0,19885.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoid-related orphan receptor gamma (ROR-gamma) signaling pathway: Summary,Summary,,
219,1159525,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway - cell viability counter screen,Confirmatory,,
220,1159526,1,1,,144211770,176,Inactive,119627033.0,3725.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the AP-1 signaling pathway,Confirmatory,,
221,1159527,1,1,,144211770,176,Inactive,325495497.0,6256.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway,Confirmatory,,
222,1159528,1,1,,144211770,176,Inactive,119627033.0,3725.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the AP-1 signaling pathway: Summary,Summary,,
223,1159529,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the RXR signaling pathway - cell viability counter screen,Confirmatory,,
224,1159531,1,1,,144211770,176,Inactive,325495497.0,6256.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the RXR signaling pathway: Summary,Summary,,
225,1159551,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoid acid receptor (RAR) signaling pathway - cell viability counter screen,Confirmatory,,
226,1159552,1,1,,144211770,176,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
227,1159553,2,1,,144211770,176,Inactive,325495463.0,5914.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the retinoic acid receptor (RAR) signaling pathway,Confirmatory,,
228,1159555,1,1,,144211770,176,Inactive,325495463.0,5914.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the retinoic acid receptor (RAR) signaling pathway: Summary,Summary,,
229,1159620,1,1,,103176092,176,Active,,,,,Summary of drug indications.,Other,,
230,1224834,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library - cell viability counter screen,Confirmatory,,
231,1224835,1,1,,144211770,176,Inactive,160794.0,,,Potency-Replicate_1,qHTS assay to identify small molecule inhibitors of firefly luciferase,Confirmatory,,
232,1224836,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
233,1224837,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway - cell viability counter screen,Confirmatory,,
234,1224838,1,1,,144211770,176,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
235,1224839,1,1,,144211770,176,Inactive,66775687.0,9970.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway,Confirmatory,,
236,1224840,3,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library - cell viability counter screen,Confirmatory,,
237,1224841,3,1,,144211770,176,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
238,1224842,3,1,,144211770,176,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library,Confirmatory,,
239,1224843,1,1,,144211770,176,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
240,1224844,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway - cell viability counter screen,Confirmatory,,
241,1224845,1,1,,144211770,176,Inactive,344243002.0,100757539.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX,Confirmatory,,
242,1224846,1,1,,144211770,176,Inactive,11995455.0,3091.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway,Confirmatory,,
243,1224847,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of H2AX - cell viability counter screen,Confirmatory,,
244,1224848,3,1,,144211770,176,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
245,1224849,3,1,,144211770,176,Inactive,325495545.0,2101.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library,Confirmatory,,
246,1224867,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 24 hour,Confirmatory,,
247,1224868,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 32 hour,Confirmatory,,
248,1224869,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 0 hour,Confirmatory,,
249,1224870,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 40 hour,Confirmatory,,
250,1224871,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 40 hour,Confirmatory,,
251,1224872,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 16 hour,Confirmatory,,
252,1224873,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 8 hour,Confirmatory,,
253,1224874,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 40 hour,Confirmatory,,
254,1224875,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 24 hour,Confirmatory,,
255,1224876,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 16 hour,Confirmatory,,
256,1224877,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 32 hour,Confirmatory,,
257,1224878,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 24 hour,Confirmatory,,
258,1224879,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 40 hour,Confirmatory,,
259,1224880,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 0 hour,Confirmatory,,
260,1224881,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 32 hour,Confirmatory,,
261,1224882,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 0 hour,Confirmatory,,
262,1224883,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 32 hour,Confirmatory,,
263,1224884,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 8 hour,Confirmatory,,
264,1224885,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 16 hour,Confirmatory,,
265,1224886,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 24 hour,Confirmatory,,
266,1224887,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HEK293 cells - 8 hour,Confirmatory,,
267,1224888,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HEK293 cells - 16 hour,Confirmatory,,
268,1224889,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS RealTime-Glo MT Cell Viability Assay in HepG2 cells - 0 hour,Confirmatory,,
269,1224890,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,A CellTox Green Cytotoxicity Assay to monitor cytotoxicity in HepG2 cells - 8 hour,Confirmatory,,
270,1224892,1,1,,144211770,176,Inactive,66775687.0,9970.0,,,qHTS assay to identify small molecule agonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
271,1224893,1,1,,144211770,176,Inactive,66775687.0,9970.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the constitutive androstane receptor (CAR) signaling pathway: Summary,Summary,,
272,1224894,1,1,,144211770,176,Inactive,11995455.0,3091.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the hypoxia (HIF-1) signaling pathway: Summary,Summary,,
273,1224895,1,1,,144211770,176,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
274,1224896,1,1,,144211770,176,Inactive,344243002.0,100757539.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of H2AX: Summary,Summary,,
275,1259241,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol - cell viability counter screen,Confirmatory,,
276,1259242,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881 - cell viability counter screen,Confirmatory,,
277,1259243,1,1,,144211770,176,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881,Confirmatory,,
278,1259244,1,1,,144211770,176,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol,Confirmatory,,
279,1259247,1,1,,144211770,176,Inactive,124375976.0,367.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the androgen receptor (AR) signaling pathway using the MDA cell line in the presence of 0.5 nM R1881: Summary,Summary,,
280,1259248,1,1,,144211770,176,Inactive,348019627.0,2099.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen receptor alpha (ER-alpha) signaling pathway using the BG1 cell line in the presence of 0.1 nM 17-beta-estradiol: Summary,Summary,,
281,1259364,1,1,,144211770,176,Inactive,1013403374.0,9734.0,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors,Confirmatory,,
282,1259365,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule HDAC inhibitors - cell viability counter screen,Confirmatory,,
283,1259366,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
284,1259367,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway - cell viability counter screen,Confirmatory,,
285,1259368,1,1,,144211770,176,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
286,1259369,1,1,,144211770,176,Inactive,109731339.0,2737.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway,Confirmatory,,
287,1259377,1,1,,144211770,176,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
288,1259378,1,1,,144211770,176,Inactive,54288833.0,2100.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway,Confirmatory,,
289,1259379,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
290,1259380,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
291,1259381,1,1,,144211770,176,Inactive,124375976.0,367.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist,Confirmatory,,
292,1259382,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway - cell viability counter screen,Confirmatory,,
293,1259383,1,1,,144211770,176,Inactive,348019627.0,2099.0,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist,Confirmatory,,
294,1259384,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen,Confirmatory,,
295,1259385,1,1,,144211770,176,Inactive,119601739.0,7253.0,,Potency-Replicate_1,qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway,Confirmatory,,
296,1259386,1,1,,144211770,176,Inactive,,,,Potency-Replicate_1,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist - cell viability counter screen,Confirmatory,,
297,1259387,1,1,,144211770,176,Inactive,124375976.0,367.0,,,qHTS assay to identify small molecule agonists of the androgen receptor (AR) signaling pathway in the presence of an antagonist: Summary,Summary,,
298,1259388,1,1,,144211770,176,Inactive,1013403374.0,9734.0,,Antagonist Potency (uM),qHTS assay to identify small molecule HDAC inhibitors: Summary,Summary,,
299,1259390,1,1,,144211770,176,Inactive,109731339.0,2737.0,,,qHTS assay to identify small molecule agonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
300,1259391,1,1,,144211770,176,Inactive,348019627.0,2099.0,,,qHTS assay to identify small molecule agonists of the estrogen receptor alpha (ER-alpha) signaling pathway in the presence of an antagonist: Summary,Summary,,
301,1259392,1,1,,144211770,176,Inactive,109731339.0,2737.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the sonic hedgehog signaling (Shh) pathway: Summary,Summary,,
302,1259393,1,1,,144211770,176,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists or antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway - wild type cell line counter screen: Summary,Summary,,
303,1259394,1,1,,144211770,176,Inactive,54288833.0,2100.0,,Ratio Potency (uM),qHTS assay to identify small molecule agonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
304,1259395,1,1,,144211770,176,Inactive,119601739.0,7253.0,,Ratio Potency (uM),qHTS assay to identify small molecule antagonists of the thyroid stimulating hormone receptor (TSHR) signaling pathway: Summary,Summary,,
305,1259396,1,1,,144211770,176,Inactive,54288833.0,2100.0,,,qHTS assay to identify small molecule antagonists of the estrogen receptor beta (ER-beta) signaling pathway: Summary,Summary,,
306,1259401,1,1,,144211770,176,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
307,1259402,1,1,,144211770,176,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor signaling pathway with the pleiotropic PPARgamma coactivator (PGC) from Tox21 10K library: Summary,Summary,,
308,1259403,1,1,,144211770,176,Inactive,325495545.0,2101.0,,Antagonist Potency (uM),qHTS assay to identify small molecule antagonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
309,1259404,1,1,,144211770,176,Inactive,325495545.0,2101.0,,,qHTS assay to identify small molecule agonists of the estrogen related receptor (ERR) signaling pathway from Tox21 library: Summary,Summary,,
310,1259407,1,1,,363903902,176,Inactive,,,,,CCRIS mutagenicity studies,Other,,
311,1259408,1,1,,363894931,176,Inactive,,,,,GENE-TOX mutagenicity studies,Other,,
